PARP INHIBITORS RESTORE TEMOZOLOMIDE SENSITIVITY IN MSH6-DEFICIENT TEMOZOLOMIDE-RESISTANT GLIOMA MODELS

被引：0
|
作者：
Higuchi, Fumi [1 ]
Wakimoto, Hiroaki [2 ]
Cahill, Daniel [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DRES-16
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [1] INHIBITION OF HOMOLOGOUS RECOMBINATION RESENSITIZES TEMOZOLOMIDE-RESISTANT GLIOMA CELLS TO TEMOZOLOMIDE
    Ohba, S.
    Hirose, Y.
    NEURO-ONCOLOGY, 2017, 19 : 63 - 64
  • [2] INHIBITION OF HOMOLOGOUS RECOMBINATION RESENSITIZES TEMOZOLOMIDE-RESISTANT GLIOMA CELLS TO TEMOZOLOMIDE
    Ohba, Shigeo
    Hirose, Yuichi
    NEURO-ONCOLOGY, 2017, 19 : 64 - 64
  • [3] Differential Characterization of Temozolomide-Resistant Human Glioma Cells
    Lai, Sheng-Wei
    Huang, Bor-Ren
    Liu, Yu-Shu
    Lin, Hsiao-Yun
    Chen, Chun-Chuan
    Tsai, Cheng-Fang
    Lu, Dah-Yuu
    Lin, Chingju
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [4] Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
    Ohba, Shigeo
    Yamashiro, Kei
    Hirose, Yuichi
    CANCERS, 2021, 13 (11)
  • [5] TARGETING FOXM1 AS A NOVEL THERAPEUTIC STRATEGY FOR THE TREATMENT OF MSH6 DEFICIENT TEMOZOLOMIDE-RESISTANT GLIOBLASTOMA
    Brierley, David J.
    Locke, Matthew
    Merve, Ashirwad
    Marino, Silvia
    Martin, Sarah A.
    NEURO-ONCOLOGY, 2014, 16
  • [6] TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS
    Jackson, Christopher
    Kalathil, Aravind
    Bindra, Ranjit
    NEURO-ONCOLOGY, 2019, 21 : 94 - 94
  • [7] Temozolomide-Resistant Glioma Cells Are Sensitive to Chloroethylating Nitrosourea Compounds in Combination with ATR Inhibitors
    Jackson, C.
    Kalathil, A. N.
    Sundaram, R. K.
    Bindra, R. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E639 - E639
  • [8] The development of MAGMAS as a potential therapeutic target in temozolomide-resistant glioma
    Tran, Jennifer D.
    Lepe, Javier J.
    Kenney, Maria C.
    Das, Bhaskar C.
    Bota, Daniela A.
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
    Quinn, Jennifer A.
    Jiang, Sara Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Friedman, Allan H.
    Bigner, Darell D.
    Sampson, John H.
    McLendon, Roger E.
    Herndon, James E., II
    Walker, Amy
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1262 - 1267
  • [10] Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines
    Jeong, Somi
    Jung, Seunghwa
    Park, Gyun-Seok
    Shin, Juhyun
    Oh, Jae-Wook
    BIOENGINEERED, 2020, 11 (01) : 791 - 800
12345